Factors Associated With the Absence of Contraception at Women Seeking a Voluntary Termination of Pregnancy
Factors Associated With the Absence of Contraception at the Time of Unplaned Pregnancy Among Women Seeking a Voluntary Termination of Pregnancy
Обзор исследования
Статус
Условия
Подробное описание
In 1967, the Neuwirth law allowed women to control their fertility by establishing the right to contraception as a principle. Since then, they have continued to take ownership of the various contraceptive methods, which are regularly renewed.
Contraceptive coverage is important in France as it is estimated that 92% of women of childbearing age use a contraceptive method. The pill remains the most widely used method of contraception (36.5%), ahead of the intrauterine device (25.6%) condoms (15.5%) Several laws have been introduced from 1967 to today to facilitate access to sexual health care: screening for sexually transmitted infections, free provision of emergency contraception to minors, non-prescription delivery of emergency contraception, free consultation at a family planning and education center, voluntary termination of pregnancy 100%, reimbursement of condoms by social security.
Despite all the measures put in place, it is now clear that the number of unplanted pregnancies is decreasing slightly and the number of abortion has remained stable since 2001.
According to the latest literature data, several socio-demographic factors appear to play a role in the rate of use of voluntary termination of pregnancy., including age, socio-cultural level, marital and economic status and ethnic origin. All the more striking, it appears that while voluntary termination of pregnancy are mainly related to contraceptive failures, one third of them involve women who do not have contraception. According to the latest Ined survey, and in accordance with other data from the literature, the factors associated with the absence of contraceptive use are multiple: ignorance about fertility, family or cultural context, cost of contraceptive methods or lack of information related to them.
While these studies have looked at the reasons given by women for the lack of contraception, with little data on the characteristics of these women, particularly socio-demographics and their reproductive history and in particular in the context of unwanted pregnancy. This finding leads us to question the factors associated with the absence of contraception among women in demand of a voluntary termination of pregnancy.
Тип исследования
Регистрация (Ожидаемый)
Контакты и местонахождение
Места учебы
-
-
-
Villeneuve-Saint-Georges, Франция
- CHI Villeneuve St Georges
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Метод выборки
Исследуемая популяция
Описание
Inclusion Criteria:
- woman of 18 years of age or older;
- Being French-speaking;
- request for a medical or instrumental voluntary termination of pregnancy
- No opposition to participation in the protocol
- Be affiliated with a social security plan
Exclusion Criteria:
- desired pregnancy
Учебный план
Как устроено исследование?
Детали дизайна
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Association between absence of contraception and socio-demographic factors, characteristics of pregnancy abortion and medical follow-up
Временное ограничение: 1 hour
|
Statistically significant association between the absence of contraception in patients consulting for a voluntary termination of pregnancy and socio-demographic factors, characteristics of voluntary termination of pregnancy abortion and characteristics related to medical follow-up
|
1 hour
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Prescription and dispensing of contraception
Временное ограничение: 1 hour
|
Prevalence of patients informed about the prescription and dispensing of contraception including emergency contraception
|
1 hour
|
|
Existence of family planning centers
Временное ограничение: 1 hour
|
Prevalence of patients informed about the existence of family planning centers
|
1 hour
|
|
Emergency contraception
Временное ограничение: 1 hour
|
Prevalence of women who have used emergency contraception
|
1 hour
|
|
Price and reimbursement of condoms
Временное ограничение: 1 hour
|
Prevalence of women informed about the price and reimbursement of condoms
|
1 hour
|
|
Knowledge of conception
Временное ограничение: 1 hour
|
Estimate the percentage of women who thought they could get pregnant at the time of the intercourse that led to this pregnancy
|
1 hour
|
|
Fertile window
Временное ограничение: 1 hour
|
Prevalence of women who use a method to track their fertile window
|
1 hour
|
|
Affection of fertility
Временное ограничение: 1 hour
|
Estimate the percentage of women who think that contraception can affect their fertility
|
1 hour
|
Соавторы и исследователи
Даты записи исследования
Изучение основных дат
Начало исследования (Ожидаемый)
Первичное завершение (Ожидаемый)
Завершение исследования (Ожидаемый)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Другие идентификационные номера исследования
- NOCONTRAIVG
- 2021-A00298-33 (Другой идентификатор: ID-RCB)
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .